Project: Reactive Oxygen Species (ROS) Activators to Treat the Rare disease Guillain-Barré Syndrome (GBS)
| Acronym | rosaGBS (Reference Number: 10082) |
| Duration | 01/04/2016 - 01/10/2018 |
| Project Topic | We will establish a novel therapeutic treatment of the orphan paralysis condition Guillain-Barré Syndrome (GBS), to enable orphan drug designation, clinical development and out-licensing to a Pharma partner. The project will also validate new In Vitro tests notably on human pluripotent stem cell-derived neural tissues to analyse neurotoxicity and optimise methodology to improve the bioavailability of compounds with difficult administration properties by medicinal chemistry and formulation. |
| Network | Eurostars 2 |
| Call | Eurostars Cut-Off 4 |